Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-02-06 Sale |
2023-02-06 7:00 pm |
aTYR PHARMA INC | LIFE | Broadfoot Jill Marie Chief Financial Officer |
1,566 | $2.36 | $3,696 | 26,710 (Direct) |
View |
| 2022-11-21 Purchase |
2022-11-21 9:04 pm |
aTYR PHARMA INC | LIFE | Shukla Sanjay President and CEO |
10,000 | $2.1405 | $21,405 | 50,798 (Direct) |
View |
| 2022-07-01 Purchase |
2022-07-06 5:02 pm |
aTYR PHARMA INC | LIFE | Shukla Sanjay President and CEO |
15,000 | $2.8776 | $43,164 | 40,798 (Direct) |
View |
| 2022-01-13 Purchase |
2022-01-18 08:39 am |
aTYR PHARMA INC | LIFE | Broadfoot Jill Marie Chief Financial Officer |
1,923 | $6.75 | $12,980 | 12,112 (Direct) |
View |
| 2022-01-07 Purchase |
2022-01-10 8:03 pm |
aTYR PHARMA INC | LIFE | Shukla Sanjay President and CEO |
5,000 | $6.7613 | $33,807 | 25,798 (Direct) |
View |
| 2021-11-15 Purchase |
2021-11-15 6:56 pm |
aTYR PHARMA INC | LIFE | Shukla Sanjay President and CEO |
2,500 | $8.575 | $21,438 | 20,798 (Direct) |
View |
| 2021-09-20 Purchase |
2021-09-22 8:19 pm |
aTYR PHARMA INC | LIFE | SCHIMMEL PAUL Director |
250,000 | $8 | $2,000,000 | 795,056 (Indirect Direct) |
View |
| 2021-05-21 Sale |
2021-05-25 9:05 pm |
aTYR PHARMA INC | LIFE | CLARKE JOHN K Director |
2,500 | $4.34 | $10,850 | 115,575 (Indirect Direct) |
View |
| 2021-05-18 Purchase |
2021-05-20 08:55 am |
aTYR PHARMA INC | LIFE | SCHIMMEL PAUL Director |
50,000 | $3.98 | $199,000 | 545,056 (Indirect Direct) |
View |
| 2021-05-18 Purchase |
2021-05-20 08:52 am |
aTYR PHARMA INC | LIFE | Shukla Sanjay President and CEO |
10,000 | $4.01 | $40,100 | 18,298 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-04-26 Exercise |
2023-04-28 4:52 pm |
N/A N/A |
aTYR PHARMA INC | LIFE | Gross Jane A Director |
6,000 | $0 | 6,000 (Direct) |
View |
| 2023-04-26 Exercise |
2023-04-28 4:51 pm |
N/A N/A |
aTYR PHARMA INC | LIFE | COUGHLIN TIMOTHY Director |
6,000 | $0 | 6,000 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-21 5:08 pm |
N/A 2033-02-16 |
aTYR PHARMA INC | LIFE | Shukla Sanjay President and CEO |
336,096 | $0 | 336,096 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-21 5:04 pm |
N/A 2033-02-16 |
aTYR PHARMA INC | LIFE | Broadfoot Jill Marie Chief Financial Officer |
84,023 | $0 | 84,023 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-21 5:00 pm |
N/A 2033-02-16 |
aTYR PHARMA INC | LIFE | DENYES NANCY General Counsel |
84,023 | $0 | 84,023 (Direct) |
View |
| 2023-02-03 Exercise |
2023-02-06 7:03 pm |
N/A N/A |
aTYR PHARMA INC | LIFE | DENYES NANCY General Counsel |
2,688 | $0 | 15,141 (Direct) |
View |
| 2023-02-03 Exercise |
2023-02-06 7:00 pm |
N/A N/A |
aTYR PHARMA INC | LIFE | Broadfoot Jill Marie Chief Financial Officer |
3,750 | $0 | 26,710 (Direct) |
View |
| 2023-02-03 Exercise |
2023-02-06 6:57 pm |
N/A N/A |
aTYR PHARMA INC | LIFE | Shukla Sanjay President and CEO |
10,375 | $0 | 92,298 (Direct) |
View |
| 2022-05-24 Option Award |
2022-05-26 4:34 pm |
N/A 2032-05-24 |
aTYR PHARMA INC | LIFE | DENYES NANCY General Counsel |
88,097 | $0 | 91,544 (Direct) |
View |
| 2022-05-24 Option Award |
2022-05-26 4:32 pm |
N/A 2032-05-24 |
aTYR PHARMA INC | LIFE | Broadfoot Jill Marie Chief Financial Officer |
75,347 | $0 | 87,637 (Direct) |
View |
| 2022-05-24 Option Award |
2022-05-26 4:30 pm |
N/A 2032-05-24 |
aTYR PHARMA INC | LIFE | Shukla Sanjay President and CEO |
516,280 | $0 | 516,280 (Direct) |
View |
| 2022-04-26 Option Award |
2022-04-28 7:57 pm |
N/A N/A |
aTYR PHARMA INC | LIFE | Zaknoen Sara Director |
6,000 | $0 | 6,000 (Direct) |
View |
| 2022-04-26 Option Award |
2022-04-28 7:53 pm |
N/A N/A |
aTYR PHARMA INC | LIFE | SCHIMMEL PAUL Director |
6,000 | $0 | 6,000 (Direct) |
View |
| 2022-04-26 Option Award |
2022-04-28 7:50 pm |
N/A N/A |
aTYR PHARMA INC | LIFE | Lucas Svetlana Director |
6,000 | $0 | 6,000 (Direct) |
View |
| 2022-04-26 Option Award |
2022-04-28 7:46 pm |
N/A N/A |
aTYR PHARMA INC | LIFE | Gross Jane A Director |
6,000 | $0 | 6,000 (Direct) |
View |
| 2022-04-26 Option Award |
2022-04-28 7:42 pm |
N/A N/A |
aTYR PHARMA INC | LIFE | COUGHLIN TIMOTHY Director |
6,000 | $0 | 6,000 (Direct) |
View |
| 2022-04-26 Option Award |
2022-04-28 7:39 pm |
N/A N/A |
aTYR PHARMA INC | LIFE | CLARKE JOHN K Director |
6,000 | $0 | 6,000 (Direct) |
View |
| 2022-02-03 Option Award |
2022-02-07 4:59 pm |
N/A 2032-02-03 |
aTYR PHARMA INC | LIFE | DENYES NANCY General Counsel |
32,250 | $0 | 32,250 (Direct) |
View |
| 2022-02-03 Option Award |
2022-02-07 4:56 pm |
N/A 2032-02-03 |
aTYR PHARMA INC | LIFE | Broadfoot Jill Marie Chief Financial Officer |
45,000 | $0 | 45,000 (Direct) |
View |
| 2022-02-03 Option Award |
2022-02-07 4:52 pm |
N/A 2032-02-03 |
aTYR PHARMA INC | LIFE | Shukla Sanjay President and CEO |
124,500 | $0 | 124,500 (Direct) |
View |
| 2021-09-20 Gift |
2021-09-22 8:19 pm |
N/A N/A |
aTYR PHARMA INC | LIFE | SCHIMMEL PAUL Director |
250,000 | $0 | 795,056 (Direct) |
View |
| 2021-05-21 Option Award |
2021-05-25 9:06 pm |
N/A 2025-05-21 |
aTYR PHARMA INC | LIFE | DENYES NANCY General Counsel |
59,000 | $0 | 62,091 (Direct) |
View |
| 2021-05-21 Option Award |
2021-05-25 9:04 pm |
N/A 2025-05-21 |
aTYR PHARMA INC | LIFE | Broadfoot Jill Marie Chief Financial Officer |
54,000 | $0 | 64,011 (Direct) |
View |
| 2021-05-21 Option Award |
2021-05-25 9:03 pm |
N/A 2025-05-21 |
aTYR PHARMA INC | LIFE | Shukla Sanjay President and CEO |
207,000 | $0 | 207,000 (Direct) |
View |
| 2021-05-21 Option Award |
2021-05-25 9:02 pm |
N/A 2031-05-21 |
aTYR PHARMA INC | LIFE | Zaknoen Sara Director |
2,285 | $0 | 2,285 (Direct) |
View |
| 2021-04-28 Option Award |
2021-04-29 8:13 pm |
N/A 2031-04-28 |
aTYR PHARMA INC | LIFE | SCHIMMEL PAUL Director |
1,428 | $0 | 1,428 (Direct) |
View |
| 2021-04-28 Option Award |
2021-04-29 8:11 pm |
N/A 2031-04-28 |
aTYR PHARMA INC | LIFE | Lucas Svetlana Director |
1,428 | $0 | 1,428 (Direct) |
View |
| 2021-04-28 Option Award |
2021-04-29 8:08 pm |
N/A 2031-04-28 |
aTYR PHARMA INC | LIFE | Gross Jane A Director |
1,428 | $0 | 1,428 (Direct) |
View |
| 2021-04-28 Option Award |
2021-04-29 8:06 pm |
N/A 2031-04-28 |
aTYR PHARMA INC | LIFE | COUGHLIN TIMOTHY Director |
1,428 | $0 | 1,428 (Direct) |
View |
| 2021-04-28 Option Award |
2021-04-29 8:02 pm |
N/A 2031-04-28 |
aTYR PHARMA INC | LIFE | CLARKE JOHN K Director |
1,428 | $0 | 1,428 (Direct) |
View |
| 2021-02-04 Option Award(A) |
2021-03-09 4:29 pm |
N/A 2031-02-04 |
aTYR PHARMA INC | LIFE | Shukla Sanjay President and CEO |
112,469 | $0 | 112,469 (Direct) |
View |